Systematic Evaluation of the Predictive Importance of Tumor Cell Content Indicators of Endoscopic Samples for Molecular Examinations in Patients with NSCLC

• Conditions: C34; Malignant neoplasm of bronchus and lung

• Registration Number: DRKS00017152
• Lead Sponsor: Ruhrlandklinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2019-05-30
• Study Start: 2019-07-22
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 66

Inclusion Criteria

NSCLC Stage IV

Exclusion Criteria

Contraindication Rigid Bronchoscopy / EBUS

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The aim of the project is to identify tumor cell content indicators of endoscopic NSCLC samples as part of the sampling process in order to ensure a successful molecular analysis of the necessary biomarkers.

Secondary Outcome Measures

Name	Time	Method
Sample weight, complications and macroscopic assessment<br>